Rutgers NJMS Logo

Department of Radiology

Nasrin Ghesani, M.D.


Section Cheif, Nuclear Medicine, University Hospital

Associate Professor

Department of Radiology
ghesannv@njms.rutgers.edu
 

University Hospital (UH)
150 Bergen Street Room H 141
Newark, NJ 07101
Phone: (973) 972-1770
Fax: (973) 972-6954

Clinical Info

Medical Expertise

Nuclear Medicine and Positron Emission Tomography
Radionuclide therapy

 

Hospital Affiliation

University Hospital, Newark

 

Insurance Participation

Insurance Participation: with Provider Number ( where applicable ) The information below is subject to change and should not be relied upon until after it is verified with the insurance company. In addition, psychiatric providers should be contacted directly for information on their participation with managed care and insurance companies.

Last Updated:

 

Languages

Hindi
Gujarati

 

Biography

Education

M.D., 1992, Government Medical College, Surat, India

 

Licensure & Certification

Medical Licensure
New Jersey


Certification

American Board of Nuclear Medicine - Nuclear Medicine

 

Languages

Hindi
Gujarati

 

Publications

Relevant Publications:

Zhuang H, Yamamoto AJ, Ghesani N, Alavi A. Detection of choriocarcinoma in the lung by FDG positron emission tomography. Clin Nucl Med. 2001 Aug;26(8):723.
Neto CA, Zhuang H, Ghesani N, Alavi A. Detection of Barrett's esophagus superimposed by esophageal cancer by FDG positron emission tomography. Clin Nucl Med. 2001 Dec;26(12):1060.
Shih WJ, Ghesani N, Hongming Z, Alavi A, Schusper S, Mozley D. F-18 FDG positron emission tomography demonstrates resolution of non-Hodgkin's lymphoma of the parotid gland in a patient with Sjogren's syndrome: before and after anti-CD20 antibody rituximab therapy. Clin Nucl Med. 2002 Feb;27(2):142-3.
Zhuang H, Cunnane ME, Ghesani NV, Mozley PD, Alavi A. Chest tube insertion as a potential source of false-positive FDG-positron emission tomographic results. Clin Nucl Med. 2002 Apr;27(4):285-6. No abstract available.
Ghesani NV, Sun X, Zhuang H, Sam JW, Alavi A. Fluorodeoxyglucose positron emission tomography excludes pericardial metastasis by recurrent lung cancer. Clin Nucl Med. 2003 Aug;28(8):666-7.
Liu Y, Ghesani N, Mirani N, Zuckier LS. PET-CT demonstration of extensive muscle metastases from breast cancer. Clin Nucl Med. 2006 May;31(5):266-8.
A level III sentinel lymph node in breast cancer. World J Surg Oncol. 2006 Jun 7;4:31. PMID: 16759381 [PubMed - in process]

 

Current Research

20160000134, NJMS Department of Orthopedics Research Fund
Ghesani (PI)
07/01/16-06/30/17
Novel Gallium 68 Citrate Imaging in Orthopedic Infections
The purpose of the current study is to demonstrate the feasibility and evaluate the accuracy of 68Gallium (68Ga)-citrate positron
emission tomography/computed tomography (PET/CT) in diagnosing prosthetic joint infection and compare it with 18fluorine-
fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) for the first time in United States. We expect
that 68Ga-citrate PET/CT will serve as a novel molecular-based sensitive functional imaging modality superior to FDG-PET/CT. We
intend to translate the results of this preliminary study to fuel larger studies in the utility of 68Ga-citrate PET/CT to evaluate
prosthesis complications, where current available imaging techniques are challenging.
Role: PI

20160000134, New Jersey Health Foundation
Marcia Blacksin (PI)
07/01/16-06/30/17
Novel Gallium 68 Citrate Imaging in Orthopedic Infections
Role: CPI

RSD1539, 2015 RSNA R&E Foundation Grants & Awards
Ghesani, Nasrin (PI)
07/01/15-06/01/17
Novel Gallium Imaging in Hepatocellular Carcinoma
The aim of the present study is to validate the uptake of novel, positron emitting radiotracer, 68Gallium Citrate in hepatocellular
carcinoma. We also aim to evaluate the sensitivity of 68Gallium (68Ga)-citrate positron emission tomography/computed tomography
(PET/CT) for the identification of intrahepatic HCC lesions in comparison with existing modalities: computed tomography (CT) alone
and magnetic resonance imaging (MRI). We expect that 68Ga-citrate PET/CT will offer a sensitive functional imaging modality for
identification of HCC lesions in the liver. We intend to use the results of this preliminary study to fuel further studies in the
utility of 68Ga-citrate PET/CT for HCC treatment monitoring.
Role: PI

1U19AI111276-01, National Institute Of Allergy And Infectious Diseases
Ellner, Gerrold (PI)
08/01/14-07/31/17
Biomarkers And Mechanisms Of Paucibacillary and Latent Tuberculosis
Role: Co-Investigator
202232 , University Research Council Grant Program
Omar Mahmoud (PI)
07/01/15-05/01/17
Biologic and Radiographic Predictive Model to Taylor Radiotherapy Management in Diffuse Large B-Cell Lymphoma



 

 

Everything A Medical School Should Be - And More

© 2014, Rutgers, The State University of New Jersey. All rights reserved.

185 South Orange Avenue, Newark, New Jersey 07101